title: Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.
authors.affiliation: Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, La 70121, USA.
authors.forename: M R
authors.initials: MR
authors.lastname: Mehra
authors.forename: H O
authors.initials: HO
authors.lastname: Ventura
authors.forename: F W
authors.initials: FW
authors.lastname: Smart
authors.forename: D D
authors.initials: DD
authors.lastname: Stapleton
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000473:pathology; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology; D016027:Heart Transplantation / Q000473:pathology*; D006801:Humans; D011183:Postoperative Complications / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D017539:Tunica Intima / Q000187:drug effects / Q000473:pathology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers